Hypothermic Oxygenated Perfusion (HOPE) downregulates the immune response in a rat model of liver transplantation

Annals of Surgery

Volumn 260, Issue 5, 2014, Pages 931-938

  Schlegel, Andrea ^a   Kron, Philipp ^a   Graf, Rolf ^a   Clavien, Pierre Alain ^b   Dutkowski, Philipp ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

HOPE; Immune response; Liver transplantation; Oxygen; Rejection

Indexed keywords

ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; REACTIVE OXYGEN METABOLITE; TACROLIMUS; OXYGEN;

ACUTE GRAFT REJECTION; ALLOTRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CELL ACTIVATION; CONFERENCE PAPER; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; FLUORESCENCE ACTIVATED CELL SORTING; GRAFT SURVIVAL; HYPOTHERMIC OXYGENATED PERFUSION; IMMUNE RESPONSE; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; KUPFFER CELL; LIVER CELL DAMAGE; LIVER FIBROSIS; LIVER GRAFT REJECTION; LIVER HISTOLOGY; LIVER PERFUSION; LIVER TRANSPLANTATION; LOW DRUG DOSE; LOW TEMPERATURE PROCEDURES; MALE; MINIMUM PLASMA CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; SURVIVAL; T LYMPHOCYTE ACTIVATION; TISSUE OXYGENATION; ANIMAL; DISEASE MODEL; GRAFT REJECTION; IMMUNOLOGY; INDUCED HYPOTHERMIA; LEWIS RAT; PERFUSION; PROCEDURES; REPERFUSION INJURY; SURVIVAL RATE;

ANIMALS; DISEASE MODELS, ANIMAL; DOWN-REGULATION; GRAFT REJECTION; HYPOTHERMIA, INDUCED; KUPFFER CELLS; LIVER TRANSPLANTATION; OXYGEN; PERFUSION; RATS; RATS, INBRED LEW; REPERFUSION INJURY; SURVIVAL RATE; TACROLIMUS;

EID: 84926096340     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000000941     Document Type: Conference Paper

References (36)

1. Leichtman AB. Balancing efficacy and toxicity in kidney-transplant immunosuppression. N Engl J Med. 2007;357:2625-2627.
2. Morard I, Mentha G, Spahr L, et al. Long-term renal function after liver transplantation is related to calcineurin inhibitors blood levels. Clin Transplant. 2006;20:96-101.
3. Toso C, Cader S, Mentha-Dugerdil A, et al. Factors predicting survival after post-transplant hepatocellular carcinoma recurrence. J Hepatobiliary Pancreat Sci. 2013;20:342-347.
4. Gutierrez-Dalmau A, Campistol JM. Immunosuppressive therapy and malignancy in organ transplant recipients: A systematic review. Drugs. 2007;67:1167-1198.
5. Dutkowski P, Schlegel A, de Oliveira M, et al. HOPE for human liver grafts obtained from donors after cardiac death. J Hepatol. 2014;60:765-772.
6. Schlegel A, Rougemont O, Graf R, et al. Protective mechanisms of endischemic cold machine perfusion in DCD liver grafts. J Hepatol. 2013;58:278- 286.
7. Schlegel A, Graf R, Clavien PA, et al. Hypothermic oxygenated perfusion (HOPE) protects from biliary injury in a rodent model of DCD liver transplantation. J Hepatol. 2013;59:984-991.
8. Dutkowski P, Graf R, Clavien PA. Rescue of the cold preserved rat liver by hypothermic oxygenated machine perfusion. Am J Transplant. 2006;6:903- 912.
9. Hu J, Wang Z, Tan CJ, et al. PlasmamicroRNA, a potential biomarker for acute rejection after liver transplantation. Transplantation. 2013;95:991-999.
10. Qin L, Guan HG, Zhou XJ, et al. Blockade of 4-1BB/4-1BB ligand interactions prevents acute rejection in rat liver transplantation. Chin Med J (Engl). 2010;123:212-215.
11. Wu YB, Huang QM, Liu JF. Establishment of a chronic rejection model for orthotopic liver transplantation in the rat. Eur Surg Res. 2011;46:94-101.
12. Cheng J, Zhou L, Jiang JW, et al. Proteomic analysis of differentially expressed proteins in rat liver allografts developed acute rejection. Eur Surg Res. 2010;44:43-51.
13. Kamada N, Calne RY. Orthotopic liver transplantation in the rat. Technique using cuff for portal vein anastomosis and biliary drainage. Transplantation. 1979;28:47-50.
14. Dutkowski P, Furrer K, Tian Y, et al. Novel short-termhypothermic oxygenated perfusion (HOPE) system prevents injury in rat liver graft from non-heart beating donor. Ann Surg. 2006;244:968-976; discussion 976-977.
15. Banff schema for grading liver allograft rejection: An international consensus document. Hepatology. 1997;25:658-663.
16. Demetris A, Adams D, Bellamy C, et al. Update of the International Banff Schema for Liver Allograft Rejection: Working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel. Hepatology. 2000;31:792-799.
17. Luer B, Koetting M, Efferz P, et al. Role of oxygen during hypothermic machine perfusion preservation of the liver. Transpl Int. 2010;23:944-950.
18. Gallinat A, Paul A, Efferz P, et al. Hypothermic reconditioning of porcine kidney grafts by short-term preimplantation machine perfusion. Transplantation. 2012;93:787-793.
19. Tang D, Kang R, Zeh HJ III, et al. High-mobility group box 1, oxidative stress, and disease. Antioxid Redox Signal. 2011;14:1315-1335.
20. Land WG. Emerging role of innate immunity in organ transplantation, part II: Potential of damage-associated molecular patterns to generate immunostimulatory dendritic cells. Transplant Rev (Orlando). 2012;26:73-87.
21. Land WG. Emerging role of innate immunity in organ transplantation, part I: evolution of innate immunity and oxidative allograft injury. Transplant Rev (Orlando). 2012;26:60-72.
22. Land WG. Emerging role of innate immunity in organ transplantation, part III: The quest for transplant tolerance via prevention of oxidative allograft injury and its consequences. Transplant Rev (Orlando). 2012;26:88-102.
23. van Golen RF, van Gulik TM, Heger M. Mechanistic overview of reactive species-induced degradation of the endothelial glycocalyx during hepatic ischemia/reperfusion injury. Free Radic Biol Med. 2012;52:1382-1402.
24. Lukacs-Kornek V, Schuppan D. Dendritic cells in liver injury and fibrosis: Shortcomings and promises. J Hepatol. 2013;59:1124-1126.
25. Sacks SH, Zhou W. The role of complement in the early immune response to transplantation. Nat Rev Immunol. 2012;12:431-442.
26. Schlichting CL, Schareck WD, Weis M. Renal ischemia-reperfusion injury: new implications of dendritic cell-endothelial cell interactions. Transplant Proc. 2006;38:670-673.
27. Zhang Q, Raoof M, Chen Y, et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature. 2010;464:104-107.
28. van Golen RF, van Gulik TM, Heger M. The sterile immune response during hepatic ischemia/reperfusion. Cytokine Growth Factor Rev. 2012;23:69- 84.
29. Peralta C, Jimenez-Castro MB, Gracia-Sancho J. Hepatic ischemia and reperfusion injury: effects on the liver sinusoidal milieu. J Hepatol. 2013;59:1094- 1106.
30. Wang Y, Wu J, Jiang B, et al. Relationship between ischemia/reperfusion injury and acute rejection of allogeneic liver transplant in rats. Transplant Proc. 2014;46:50-55.
31. Ishii E, Shimizu A, Kuwahara N, et al. Hepatic artery reconstruction prevents ischemic graft injury, inhibits graft rejection, and mediates longterm graft acceptance in rat liver transplantation. Transplant Proc. 2013;45: 1748-1753.
32. Shimizu A, Ishii E, Kuwahara N, et al. Chronic antibody-mediated responses maymediate chronic rejection in rat orthotopic liver transplantation. Transplant Proc. 2013;45:1743-1747.
33. Vincenti F. Immunosuppression minimization: current and future trends in transplant immunosuppression. J Am Soc Nephrol. 2003;14:1940-1948.
34. Barbier L, Garcia S, Cros J, et al. Assessment of chronic rejection in liver graft recipients receiving immunosuppression with low-dose calcineurin inhibitors. J Hepatol. 2013;59:1223-1230.
35. Knolle PA, Thimme R. Hepatic immune regulation and its involvement in viral hepatitis infection. Gastroenterology. 2014;46:1193-1207.
36. Vivarelli M, Dazzi A, Cucchetti A, et al. Sirolimus in liver transplant recipients: A large single-center experience. Transplant Proc. 2010;42:2579-2584.